Ellevest Inc’s Assembly Biosciences ASMB Stock Holding History

Ellevest Inc’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1	Closed	–	–	1189
2020 Q3	$0	Hold	1	–	–	﹤0.01%	1132
2020 Q2	$0	Hold	1	–	–	﹤0.01%	1127
2020 Q1	$0	Buy	+1	New	+$214	﹤0.01%	1082

Other funds holding ASMB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Ellevest Inc's ASMB Position: Q4 2020 in Review

Ellevest Inc sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 1 share.

Ellevest Inc first reported a position in ASMB in Q1 2020 and held it in 3 quarters. The position peaked at $0 in Q3 2020. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

Ellevest Inc reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
Ellevest Inc sold 1 Assembly Biosciences share in Q4 2020.
Ellevest Inc first reported a position in Assembly Biosciences in Q1 2020 and held it in 3 quarters.
Ellevest Inc's Assembly Biosciences position peaked at $0 in Q3 2020.
109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on Ellevest Inc's 13F filing for Q4 2020, filed 4 Feb 2021.